Islet amyloid polypeptide gene promoter polymorphisms are not associated with Type 2 diabetes or with the severity of islet amyloidosis
- 15 April 2005
- journal article
- research article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1740 (1) , 74-78
- https://doi.org/10.1016/j.bbadis.2005.02.001
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Mutation at position −132 in the islet amyloid polypeptide (IAPP) gene promoter enhances basal transcriptional activity through a new CRE-like binding siteDiabetologia, 2004
- Islet amyloid: a complication of islet dysfunction or an aetiological factor in Type 2 diabetes?Diabetologia, 2004
- Studies of variability in the islet amyloid polypeptide gene in relation to Type 2 diabetesDiabetic Medicine, 2003
- Amylin gene promoter mutations predispose to Type 2 diabetes in New Zealand MaoriDiabetologia, 2003
- Islet Amyloid Develops Diffusely Throughout the Pancreas Before Becoming Severe and Replacing Endocrine CellsDiabetes, 2001
- Diabetes mellitus in Macaca mulatta monkeys is characterised by islet amyloidosis and reduction in beta-cell populationDiabetologia, 1993
- The insulin and islet amyloid polypeptide genes contain similar cell-specific promoter elements that bind identical beta-cell nuclear complexes.Molecular and Cellular Biology, 1992
- ISLET AMYLOID FORMED FROM DIABETES-ASSOCIATED PEPTIDE MAY BE PATHOGENIC IN TYPE-2 DIABETESThe Lancet, 1987
- Immunohistochemical morphometry of pancreatic endocrine cells in diabetic, normoglycaemic glucose-intolerant and normal catsJournal of Comparative Pathology, 1986
- Das Amyloid der Langerhansschen Inseln und seine Beziehung zum Diabetes mellitus* 1Deutsche Medizinische Wochenschrift (1946), 1980